ID   PH5T
AC   CVCL_VK97
DR   Wikidata; Q98128578
RX   PubMed=7832798;
RX   PubMed=8925135;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141fs (c.422delG); Zygosity=Unspecified (PubMed=8925135).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK96 ! PH5CH
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
RX   PubMed=7832798; DOI=10.1006/bbrc.1995.1123;
RA   Kato N., Nakazawa T., Mizutani T., Shimotohno K.;
RT   "Susceptibility of human T-lymphotropic virus type I infected cell
RT   line MT-2 to hepatitis C virus infection.";
RL   Biochem. Biophys. Res. Commun. 206:863-869(1995).
//
RX   PubMed=8925135; DOI=10.1007/BF02723678;
RA   Noguchi M., Hirohashi S.;
RT   "Cell lines from non-neoplastic liver and hepatocellular carcinoma
RT   tissue from a single patient.";
RL   In Vitro Cell. Dev. Biol. Anim. 32:135-137(1996).
//